Health and Human Services Secretary Robert F. Kennedy Jr recently highlighted potential risks of acetaminophen or tylenol, including ties to autism, ADHD, and liver toxicity in children, during an October 9, White House cabinet meeting with President Donald Trump. The US Department of HHS announced plans for FDA warnings on prenatal use, updated safety labels for over-the-counter products, and a public education campaign promoting alternatives and minimal dosing. While scientific studies show mixed results on neurodevelopmental links and causation, liver toxicity from overdoses remains a well-documented concern, prompting this policy push amid ongoing debates. Well, today, we ought to look further into the US Department of HHS’s doubling down on acetaminophen.
CONTEXTUALISATION: THE SEPTEMBER 22ND ANNOUNCEMENT
“The US HHS’s Doubledown on Acetaminophen (or Tylenol)”, and we ought to begin with some contextualisation, looking at the announcement on the 22nd of September. Well, speaking from the Roosevelt Room, President Donald Trump and US Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr announced bold new actions to confront the autism spectrum disorder (ASD) epidemic in America, which has surged nearly 400% since 2000 and now affects 1 in 31 American children.
First, the US Food and Drug Administration (or the FDA) will act on a potential treatment for speech-related deficits associated with ASD. The FDA is publishing a Federal Register notice outlining a label update for leucovorin for cerebral folate deficiency, which has been associated with autism. This action establishes the first FDA-recognised therapeutic for children with cerebral folate deficiency and autistic symptoms. The change will essentially authorise treatment for children with ASD, with continued use if children show language, social, or adaptive gains. Following the label update for ASD, state Medicaid programs will be able to cover leucovorin for the indication of ASD, in partnership with the Centers for Medicare & Medicaid Services (CMS). Finally, the National Institutes of Health (NIH) will launch confirmatory trials and new research into the impact of leucovorin including safety studies.
Now, it is very key to note that leucovorin is not a cure for ASD and may only lead to improvements in speech-related deficits for a subset of children with ASD. In addition, leucovorin would have to be administered under close medical supervision and in conjunction with other non-pharmacological approaches for children with ASD (e.g., behavioral therapy).
Then the second point of contextualisation to highlight from the announcement on the 22nd of September is that HHS stated that it will also act on acetaminophen. In essence, the FDA responsibility was to issue a physician notice and begin the process to initiate a safety label change for acetaminophen (or Tylenol and similar products). HHS would also have the responsibility of launching a nationwide public service campaign to inform families and protect public health.
TRUMP OPPOSES HEPATITIS B VACCINE FOR BABIES, & WARNS OF METALS IN VACCINES
Now one of the striking details mentioned by prescient Trump in the course of the tylenol-autism link announcement is that he questioned the rationale of giving an infant a Hepatitis B vaccine, as well the many dangerous metals, like aluminium and mercury in vaccines. Now, he proceeds to advocate for spacing out vaccines, as opposed to eradicating them in their entirety, which is not as fundamentalist and accurate a response to vaccines as I would argue is necessary. However, his remarks are considered in the context of a world and American society where people still have the freedom to exercise the choice to take a vaccine even when they are told about their harms. But, I am hoping to see and praying for this more fundamentalist and emphatically anti-vaccine approach to become more intrinsic to US health policy, because, we have spent a lot of time challenging the rationale behind vaccine science, and also disproving their claimed efficacy (including here on The War Room, and LN24 International at large) for us not to advocate for progressing towards a direct refutation of the necessity or plausibility of vaccines.
Nevertheless, here is why it still matters that Trump is perhaps the first president in US and world history to raise concerns about the Hepatitis B vaccines of the first day out of the womb, and also the presence of metals like aluminium and mercury in vaccines. First, central to the vaccine agenda and hoax, as far as it relates to children, is the idea that the many vaccines that parents are being compelled to allow for their children are somehow necessary. Following his rationale, within hours or when a child is born, a child is subjected to pharmaceutical intervention: more specifically, a new newborn’s eyes are smeared with erythro-mycin ointment, and a newborn is given the Hepatitis B shot.
However, erythromycin ointment is to prevent gonorrhoea or chlamydia infections of the eyes; and so, why would a newborn need this if the mother does not have these sexually transmitted illnesses? Furthermore, Hepatitis B is also a sexually transmitted disease, and from IV drug abusers, and so why would a newborn need this if parents are healthy and do not have Hepatitis B? Especially since parents are tested for these illnesses! In essence, the logic behind the alleged necessity of these interventions is really about treating newborns for illnesses they do NOT have – because there is literally nothing causal and therefore expressly necessary that would warrant these pharmaceutical interventions. Therefore, in questioning the rationale behind giving newborns the Hepatitis B jab, President Trump is exposing the deceptive reasoning behind it, and subsequently disrupting the vaccine enterprise’s profit stream that is built on the backs of babies.
Secondly, metals in vaccines are actually a massive health concern. Dr Toby Rogers PhD exposed the fact that the FDA and CDC approved aluminum as ‘safe & effective’ in vaccines, based on a study of only 4 rabbits that was riddled with issues – and yet, this is the study that the FDA and CDC rely on. In this study, they promptly lost the results from one of the rabbits. So the study is actually based on just 3 rabbits. But, the results in the rabbits were nevertheless of great concern.
In essence, the rabbits were killed after 28 days and the Aluminum Adjuvants are still there. At the endpoint, Aluminum retention in the body and organs was 94% for Aluminum Hydroxide and 78% for Aluminum Phosphate. The theory and narrative told by the FDA and CDC has always been that the body excretes the Aluminum through the urine and is therefore harmless. BUT, Dr Toby Rogers explained that nothing could be further from the truth. Injected heavy metals actually stay in the places in the body you would expect, which include the kidneys, the liver, the heart, the lymph nodes, the bone marrow and the brain.”
And so, clearly the study by the CDC and the FDA was terrible to begin with but also produced results that were concerning. BUT, despite this, the FDA and CDC declared the presence of metals in vaccines to be safe and effective. It is beyond absurd because the science is so terribly bad that anybody who reads that study would not want to inject their children with Aluminum Adjuvanted vaccines. And that’s just one ingredient amongst hundreds in these vaccines, as far as metals are concerned. Here’s more from Dr Toby Rogers.
RFK JR: TYLENOL NOT JUST LINKED TO AUTISM, BUT ALSO ADHD AND LIVER TOXICITY
Then, in a recent announcement this month of October, and in doubling down on the tylenol issue, Secretary Kennedy announced that Tylenol is NOT just linked to autism but also ADHD and liver toxicity in children. Let’s kindly revisit that moment.
THE POINT OF CONTENTION: IS ACETAMINOPHEN A CAUSE OR DRIVER OF AUTISM?
So, all that we’ve discussed and heard thus far contextualises the contribution from the White house as far as tylenol (and vaccines) are concerned. Which then brings us to the point of contention. Now, for clarity, what is NOT the point of contention (at least for the purpose of our discussion is that the FDA recognises that acetaminophen is often treated as the only tool (or most recommended tool) for fevers and pain in pregnancy, as other alternatives (e.g., NSAIDs) have well documented adverse effects; which is why the FDA is also partnering with manufacturers to update labeling and drive new research to safeguard mothers, children, and families – this is not the point of contention we will focus on, because acetaminophen certainly has health risks (which we will highlight as we proceed), and these are health risks that do not warrant a defence, and rather necessitate a shift away from a reliance on pharmaceutical drugs as a means of pain or fever relief – especially in young children.
Then, what IS a point of contention that we ought to address for the purpose of our discussion, looking at the The US HHS’s Doubledown on Acetaminophen (or Tylenol) is one that began with a crucial concession from the White House concerning acetaminophen, and it is that the FDA recognises that there are contrary studies showing no association between acetaminophen and autism. Thus, given the conflicting literature and lack of clear causal evidence, the HHS stated on the 22nd of September that it wants to encourage clinicians to exercise their best judgment in use of acetaminophen. As such, the point of contention lies with the conflicting literature, and this is precisely what we’ll talk about, by asking the question of whether acetaminophen is a root cause of driver in the autism or neurodevelopmental health issue discussion.
To begin our focus on this point of contention, I’d like to prove not only that tylenol had already been a focus in the autism debate years before the announcement from the White house in September, but I’d also like to prove that the studies even years back were showing that tylenol played the role of increasing chances of autism after vaccination, as opposed to being a primary cause itself. Kindly watch this excerpt from a 2023 interview conducted by the Children’s Health Defence.
Once again, President Trump raised the alarm about the dramatically rising prevalence of autism, and he emphasised that it must be caused by something in the environment. He mentioned acetaminophen and hyper-vaccination as prime suspects. Now, while president Trump and HHS Secretary also spoke about the suspect of large vaccine bundles administered to infants, their medical advisors (which include Drs Jay Bhattacharya, Marty Makary, Mehmet Oz, and Dorothy Fink) focused their remarks exclusively on Tylenol, and almost did not mention vaccines.
But, here is what I’d like for us to collectively reconsider. First, there have been studies that examined Tylenol among the potential causes of autism, including studies by the McCullough Foundation, led by Dr Peter McCullough, who is among the people at the forefront of performing an exhaustive investigation of autism. These studies have found little evidence to warrant regarding Tylenol as a prime suspect in autism causation. In fact, it would seem that interest in the purported Tylenol-Autism link has recently been piqued within the same institutions that have long vehemently denied that autism is linked to childhood vaccination.
Thus, the totality of circumstances suggests that Tylenol is more of a red-herring than a true suspect. Now, this is not to say that tylenol is an exceptional pharmaceutical product, rather, it is to say that studies do not support it emerging as a primary cause of autism. In fact, I find it interesting that the recent study pointing to Tylenol is from Havard – the same institution that brought us the brain death definition to cover up for the disastrous second heart transplant that took place in Brooklyn, New York; and has resulted in the murder of many patients who are claimed to have been so-called brain dead.
Secondly, since it became a widely used, over-the-counter drug in 1960, Tylenol has been the only recommended medicine for relieving pain and reducing fever in pregnant women and infants. Generation X (which are those born between 1965-1980) was exposed to Tylenol in utero, and their mothers often gave it to them to lower their fevers from frequent earaches. And yet, in a 1970 birth cohort, autism was virtually unknown. BY CONTRAST, the trend of dramatically increasing autism began in the late eighties, following the passage of the National Childhood Vaccine Injury Act of 1986. This Act granted liability protection to vaccine manufacturers, which was followed by a rapid proliferation of the number of shots on the childhood schedule.
So, what does this mean? I think it means that tylenol – at best – is a driver (or worsening agent) of neurodevelopmental issues, but not the root cause. Let’s begin with Prenatal Exposure. The most comprehensive review to date, by Prada et al, evaluated tylenol use during pregnancy: 27 studies found a positive association with neurodevelopmental disorders (in particular ASD/ADHD). Then, 9 studies showed no link, while 4 studies suggested protective effects. But, we also ought to consider that autism was never or rarely ever diagnosed at birth. In every study, it emerged years later—typically ages 2–8, the very same window when children are loaded with many vaccines. Meanwhile, none of these papers we referenced accounted for vaccination as a confounder. This shows prenatal Tylenol exposure may predispose children, but the neurological injuries are detected during the vaccine years.
Similarly, when we look at Postnatal Exposure to tylenol, a study by Schultz et al (in 2008) found that children given Tylenol after MMR vaccination were about six times more likely to later be diagnosed with autism. In those who regressed (meaning who lost previously acquired skills), the risk was nearly fourfold, and in those with clear post-vaccine complications, the risk spiked to over eightfold. By contrast, ibuprofen showed no association. In addition, Yengst et al (in a 2025 study) found that in a Medicaid cohort of over 674,000 children, repeated episodes of fever, ear infections, or other “Tylenol-triggering” illnesses were linked to a two and a half-fold higher risk of autism. Among girls with multiple fevers, the risk climbed to nearly fourfold.
Taken together, these studies reveal a consistent pattern: which is that autism risk intensifies in the post-vaccine period, when febrile reactions are most common, and tylenol use in this context may amplify the likelihood of developmental regression. This is considering that tylenol depletes what is called gluta-thione, and this is the body’s master antioxidant/detox system, exactly when the brain faces inflammatory/oxidative stress (such as fever, seizures, or immune activation). Now, some pediatric practices have actually recommended Tylenol before vaccine visits “just in case,” meaning that children who take tylenol before shots arrive with defenses already depleted as the shots provoke fever/immune activation—thus priming the children for worse outcomes. Ergo, tylon is a driver (or worsening agent) but not the cause of neurodevelopmental issues.
CONTRASTING THE CHILDHOOD VACCINE SCHEDULE WITH TYLENON IN THE CAUSATION DISCOURSE
So, that is what studies reflect concerning tylenol’s capacity as a root cause in neurodevelopmental issues – and especially autism. Let’s proceed to contrast this with the childhood vaccine schedule. You’d recall that on the 9th of September, attorney Aaron Siri testified before the US Senate’s Permanent Subcommittee on Investigations during the hearing titled: “How the Corruption of Science has Impacted Public Perception and Policies Regarding Vaccines.” In his sworn testimony, Siri revealed the results of a long-hidden study from the Henry Ford Health System in Detroit, MI. This is the largest vaccinated vs unvaccinated birth cohort study ever conducted in the United States (looking at 18,468 participants). Children were tracked from birth over a 10-year period. The data were drawn directly from electronic medical records — the gold standard for real-world health outcomes.
The study’s official title is (quote): “Impact of Childhood Vaccination on Short- and Long-Term Chronic Health Outcomes in Children: A Birth Cohort Study.” The measures and outcomes of this study come directly from the testimony of Aaron Siri, who presented these findings under oath in the US Senate, as unfortunately, the study is not yet publicly available (again, considering that it was largely hidden for the longest time).
The key findings from the Henry Ford Health System study found that, compared to unvaccinated children, those who received one or more vaccines had dramatically higher rates of chronic illness; specifically 329% more asthma, 203% more atopic disease, 496% more autoimmune disease, 453% more neurodevelopmental disorders, 228% more developmental delays, and 347% more speech disorders. In light of these findings, Aaron Siri testified that all of these findings were statistically significant. And even more striking is that, in conditions where unvaccinated children had zero cases (and this is looking at conditions like brain dysfunction, ADHD, learning disabilities, intellectual disabilities, and tics), there were hundreds of cases among the vaccinated group!
Written By Lindokuhle Mabaso
